Acebutolol pharmacokinetics in renal failure

Area of Science:

• Pharmacokinetics
• Nephrology
• Clinical Pharmacology

Background:

• Acebutolol is a beta-blocker used for cardiovascular conditions.
• Understanding drug metabolism and excretion is crucial for patient safety and effective dosing.
• Renal function plays a significant role in the elimination of many drugs.

Purpose of the Study:

• To investigate the influence of varying renal function on the pharmacokinetics of acebutolol and its metabolite, diacetolol.
• To determine the primary route of excretion for acebutolol and diacetolol.

Main Methods:

• Single oral dose administration of 200 mg acebutolol to 17 individuals with diverse renal function.
• Measurement of plasma half-life, elimination rate constant, and area under the curve (AUC).
• Correlation analysis between pharmacokinetic parameters and markers of renal function (creatinine clearance, serum creatinine).

Main Results:

• Acebutolol plasma half-life and elimination rate showed significant variation but did not correlate with renal impairment.
• A strong correlation was observed between the renal clearance of creatinine and acebutolol.
• Diacetolol, the acetyl metabolite, exhibited substantial inter-individual variability (10-fold in half-life/elimination rate, 40-fold in AUC) that significantly correlated with renal function markers.

Conclusions:

• Renal elimination is the primary excretion route for diacetolol, not acebutolol.
• Individual renal function is a critical factor in the variability of diacetolol pharmacokinetics.